Trifork Group Reports 7.2% Revenue Growth in 2025, Initiates Share Buyback and Strategic Review of Labs
Event summary
- Trifork Group reported full-year 2025 revenue growth of 7.2% to EURm 220.9, with adjusted EBITDA margin improving to 13.6%.
- Products segment grew by 37.6%, now representing 35.2% of total revenue, while Services revenue declined by 4.1%.
- The company initiated a EURm 10 share buyback program and began a strategic review of options for Trifork Labs.
- Fourth-quarter 2025 saw organic growth of 9.4%, with Products revenue increasing by 27.0% and adjusted EBITDA margin reaching 18.1%.
- For 2026, Trifork Group expects revenue between EURm 230-240 and adjusted EBITDA margin between 14.6-17.4%.
The big picture
Trifork Group's shift towards a product-led model is gaining traction, with significant growth in its Products segment driven by demand for data sovereignty solutions and e-health platforms. The strategic review of Trifork Labs suggests a potential divestment or restructuring to optimize capital allocation, reflecting broader trends in tech companies focusing on core business profitability. With improved margins and strong cash conversion, the company is positioning itself for further growth and value realization in 2026.
What we're watching
- Product-Led Transition
- Whether Trifork can sustain the rapid growth of its Products segment and reach the target of 50% of total revenue.
- Capital Allocation
- The pace at which Trifork will execute further share buybacks or M&A activities following the EURm 10 buyback initiation.
- Strategic Review Impact
- How the strategic review of Trifork Labs will affect the company's focus and capital allocation to its core business.
Related topics